Workup and Staging of Locally Advanced Breast Cancer

Seminars in Radiation Oncology

Volumn 19, Issue 4, 2009, Pages 211-221

  Whitman, Gary J ^a   Strom, Eric A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BONE SCINTISCANNING; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAMMOGRAPHY; MICROMETASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; THORAX RADIOGRAPHY; TREATMENT PLANNING;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; SENTINEL LYMPH NODE BIOPSY; ULTRASONOGRAPHY, MAMMARY;

EID: 69249230995     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2009.05.006     Document Type: Review

References (60)

1. Giordano S.H. Update on locally advanced breast cancer. Oncologist 8 (2003) 521-530
2. Franceschini G., Terribile D., Magno S., et al. Update in the treatment of locally advanced breast cancer: A multidisciplinary approach. Eur Rev Med Pharmacol Sci 11 (2007) 283-289
3. Cristofanilli M., Valero V., Buzdar A.U., et al. Inflammatory breast cancer (IBC) and patterns of recurrence: Understanding the biology of a unique disease. Cancer 110 (2007) 1436-1444
4. Prati R., Minami C.A., Gornbein J.A., et al. Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy. Cancer 115 (2009) 1194-1202
5. Gonzalez-Angulo A.M., Morales-Vasquez F., and Hortobagyi G.N. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 608 (2007) 1-22
6. Chia S., Swain S.M., Byrd D.R., et al. Locally advanced and inflammatory breast cancer. J Clin Oncol 26 (2008) 786-790
7. Shen J., Valero V., Buchholz T.A., et al. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol 11 (2004) 854-860
8. Londero V., Bazzocchi M., del Frate C., et al. Locally advanced breast cancer: Comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 14 (2004) 1371-1379
9. Bonnema J., van Geel A.N., van Ooijen B., et al. Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: New diagnostic method. World J Surg 21 (1997) 270-274
10. Berg W.A., and Gilbreath P.L. Multicentric and multifocal cancer: Whole-breast US in preoperative evaluation. Radiology 214 (2000) 59-66
11. Moon W.K., Noh D.Y., and Im J.G. Multifocal, multicentric, and contralateral breast cancers: Bilateral whole-breast US in the preoperative evaluation of patients. Radiology 224 (2002) 569-576
12. Pendas S., Jakub J., Giuliano R., et al. The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapy. Cancer Control 11 (2004) 231-235
13. Bedrosian I., Bedi D., Kuerer H.M., et al. Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 10 (2003) 1025-1030
14. Khan A., Sabel M.S., Nees A., et al. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy. Ann Surg Oncol 12 (2005) 697-704
15. Podkrajsek M., Music M.M., Kadivec M., et al. Role of ultrasound in the preoperative staging of patients with breast cancer. Eur Radiol 15 (2005) 1044-1050
16. Klauber-Demore N., Kuzmiak C., Rager E.L., et al. High-resolution axillary ultrasound is a poor prognostic test for determining pathologic lymph node status in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer. Am J Surg 188 (2004) 386-389
17. Whitman G.J., Sheppard D.G., Phelps M.J., et al. Breast cancer staging. Semin Roentgenol 41 (2006) 91-104
18. Yang W.T., Chang J., and Metreweli C. Patients with breast cancer: Differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes. Radiology 215 (2000) 568-573
19. Feu J., Tresserra F., Fabregas R., et al. Metastatic breast carcinoma in axillary lymph nodes: In vitro US detection. Radiology 205 (1997) 831-835
20. Amaral B.B., Meurer L., Whitman G.J., et al. Lymph node status in the breast cancer patient: Sampling techniques and prognostic significance. Semin Roentgenol 42 (2007) 253-264
21. Krishnamurthy S., Sneige N., Bedi D.G., et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 95 (2002) 982-988
22. Topal U., Punar S., Tasdelen I., et al. Role of ultrasound-guided core needle biopsy of axillary lymph nodes in the initial staging of breast carcinoma. Eur J Radiol 56 (2005) 382-385
23. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC Cancer Staging Manual. (ed 6) (2002), Springer, New York, NY 223-240
24. March D.E., Wechsler R.J., Kurtz A.B., et al. CT-pathologic correlation of axillary lymph nodes in breast carcinoma. J Comput Assist Tomogr 15 (1991) 440-444
25. Chung A., Liou D., Karlan S., et al. Preoperative FDG-PET for axillary metastases in patients with breast cancer. Arch Surg 141 (2006) 783-789
26. Gil-Rendo A., Martinez-Requeira F., Zornoza G., et al. Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer. Br J Surg 96 (2009) 166-170
27. McIntosh S.A., Ogston K.N., Payne S., et al. Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. Am J Surg 185 (2003) 525-531
28. Shanta V., Swaminathan R., Rama R., et al. Retrospective analysis of locally advanced noninflammatory breast cancer from Chennai, South India, 1990-99. Int J Radiat Oncol Biol Phys 70 (2008) 51-58
29. Beenken S.W., Urist M.M., Zhang Y., et al. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann Surg 237 (2003) 732-739
30. Altinyollar H., Dingil G., and Berberoglu U. Detection of infraclavicular lymph node metastases using ultrasonography in breast cancer. J Surg Oncol 92 (2005) 299-303
31. Iyengar P., Strom E.A., Zhang Y.-J., et al. Locally advanced breast cancer frequently involves the extra-axillary regional nodes: Incidence and treatment impact. Cancer Res 69 suppl (2009) 257s (abstr)
32. Helyer S.J., Moskovic E., Ashley S., et al. A study testing the routine use of ultrasound measurements when selecting the electron energy for breast boost radiotherapy. Clin Oncol (R Coll Radiol) 11 (1999) 164-168
33. Rabinovitch R., Finlayson C., Pan Z., et al. Radiographic evaluation of surgical clips is better than ultrasound for defining the lumpectomy cavity in breast boost treatment planning: A prospective clinical study. Int J Radiat Oncol Biol Phys 47 (2000) 313-317
34. Coles C., Cash C.J., Treece G.M., et al. High definition three-dimensional ultrasound to localise the tumour bed: A breast radiotherapy planning study. Radiother Oncol 84 (2007) 233-241
35. Phillips S.W., Gabriel H., Comstock C.E., et al. Sonographically guided metallic clip placement after core needle biopsy of the breast. AJR Am J Roentgenol 175 (2000) 1353-1355
36. Braeuning M.P., Burke E.T., and Pisano E.D. Embolization coils as tumor markers for mammography in patients undergoing neoadjuvant chemotherapy for carcinoma of the breast. AJR Am J Roentgenol 174 (2000) 251-252
37. Oh J.L., Nguyen G., Whitman G.J., et al. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110 (2007) 2420-2427
38. Gittleman M.A. Single-step ultrasound localization of breast lesions and lumpectomy procedure. Am J Surg 186 (2003) 386-390
39. Bennett I.C., Greenslade J., and Chiam H. Intraoperative ultrasound-guided excision of nonpalpable breast lesions. World J Surg 29 (2005) 369-374
40. Paramo J.C., Landeros M., McPhee M.D., et al. Intraoperative ultrasound-guided excision of nonpalpable breast lesions. Breast J 5 (1999) 389-394
41. Morris E.A. Breast cancer staging with MRI. Radiol Clin North Am 40 (2002) 443-466
42. Berg W.A., Gutierrez L., NessAiver M.S., et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233 (2004) 830-849
43. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356 (2007) 1295-1303
44. Kim H.J., Im Y.H., Han B.K., et al. Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: Relation to response patterns on MRI. Acta Oncol 46 (2007) 996-1003
45. Julius T., Kemp S.E., Kneeshaw P.J., et al. MRI and conservative treatment of locally advanced breast cancer. Eur J Surg Oncol 31 (2005) 1129-1134
46. Michel S.C., Keller T.M., Frohlich J.M., et al. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 225 (2002) 527-536
47. Stadnik T.W., Everaert H., Makkat S., et al. Breast imaging. Preoperative breast cancer staging: Comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging-Initial findings. Eur Radiol 16 (2006) 2153-2160
48. Memarsadeghi M., Riedl C.C., Kaneider A., et al. Axillary lymph node metastases in patients with breast carcinomas: Assessment with nonenhanced versus USPIO-enhanced MR imaging. Radiology 241 (2006) 367-377
49. Cox C.E., Cox J.M., White L.B., et al. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer. Ann Surg Oncol 13 (2006) 483-490
50. Bombardieri E., and Gianni L. The choice of the correct imaging modality in breast cancer management. Eur J Nucl Med Mol Imaging 31 suppl 1 (2004) S179-S186
51. Al-Husaini H., Amir E., Fitzgerald B., et al. Prevalence of overt metastases in locally advanced breast cancer. Clin Oncol (R Coll Radiol) 20 (2008) 340-344
52. Mahner S., Schirrmacher S., Brenner W., et al. Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-d-glucose, conventional imaging and computed tomography for staging of breast cancer. Ann Oncol 19 (2008) 1249-1254
53. 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer. J Clin Oncol 22 (2004) 1253-1259
54. Wahl R.L., Siegel B.A., Coleman R.E., et al. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: A report of the staging Breast Cancer with PET Study Group. J Clin Oncol 22 (2004) 277-285
55. Bellon J.R., Livingston R.B., and Eubank W.B. Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC). Am J Clin Oncol 27 (2004) 407-410
56. Baslaim M.M., Bakheet S.M., Bakheet R., et al. 18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer. World J Surg 27 (2003) 1099-1104
57. Tatsumi M., Cohade C., Mourtzikos K.A., et al. Initial experience with FDG-PET/CT in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging 33 (2006) 254-262
58. Carkaci S., Macapinlac H.A., Cristofanilli M., et al. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: Preliminary data. J Nucl Med 50 (2009) 231-238
59. Rosen E.L., Eubank W.B., and Mankoff D.A. FDG PET, PET/CT and breast cancer imaging. Radiographics 27 suppl 1 (2007) S215-S229
60. 18F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 18 (2000) 1689-1695